Somnolence: Difference between revisions

Jump to navigation Jump to search
Line 47: Line 47:
** [[Antihypertensive]] medications like [[amlodipine]]
** [[Antihypertensive]] medications like [[amlodipine]]
** [[Hypnotics]] like [[zopiclone]], or the [[benzodiazepine]] such as [[diazepam]] or [[nitrazepam]] and the [[barbiturate]], such as [[amobarbital]] or [[secobarbital]]
** [[Hypnotics]] like [[zopiclone]], or the [[benzodiazepine]] such as [[diazepam]] or [[nitrazepam]] and the [[barbiturate]], such as [[amobarbital]] or [[secobarbital]]
** Central nervous system agents like [[Carisoprodol]]
** Central nervous system agents like [[Carisoprodol]], [[Metaxalone]]
** Other agents impacting the [[central nervous system]] in sufficient or toxic doses
** Other agents impacting the [[central nervous system]] in sufficient or toxic doses
* [[Sleep apnea]]
* [[Sleep apnea]]

Revision as of 20:02, 24 October 2014

For patient information, click here

Somnolence
ICD-10 R40.0
ICD-9 780.09

Template:Search infobox Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]

Overview

Somnolence (or "drowsiness") is a state of near-sleep, a strong desire for sleep, or sleeping for unusually long periods. It has two distinct meanings, referring both to the usual state preceding falling asleep, and the chronic condition referring to being in that state independent of a circadian rhythm. The disorder characterized by the latter condition is most commonly associated with users of prescription hypnotics, such as mirtazapine or zolpidem.

It is considered a lesser impairment of consciousness than stupor or coma.

Causes

Hazards

Somnolence can be dangerous when performing tasks that require constant concentration, such as driving a vehicle. When a person is sufficiently fatigued, he or she may experience microsleeps (loss of concentration).

See also

References

  1. Zimmermann C, Pfeiffer H (January 2007). "[Sleep disorders in depression. Suggestions for a therapeutic approach]". Nervenarzt (in German). 78 (1): 21–30. doi:10.1007/s00115-006-2111-1. PMID 16832696.
  2. Watanabe N, Omori IM, Nakagawa A; et al. (2011). "Mirtazapine versus other antidepressive agents for depression". Cochrane Database Syst Rev (12): CD006528. doi:10.1002/14651858.CD006528.pub2. PMID 22161405.
  3. "http://www.dsm5.org/Pages/Default.aspx". External link in |title= (help)

Template:Cognition, perception, emotional state and behaviour symptoms and signs Template:SleepSeries2

Template:Disease-stub